Skip to main content
SpringerLink
Log in

Histological Considerations of Glaucoma Drainage Devices

  • Chapter
  • First Online:
Book cover Glaucoma Drainage Devices

  • 489 Accesses

Abstract

The fundament of glaucoma surgery is to artificially create an additional pathway for aqueous humor outflow, with a consequent lowering of IOP (Fig. 19.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amoozgar B, Lin SC, Han Y, Kuo J. A role for antimetabolites in glaucoma tube surgery: current evidence and future directions. Curr Opin Ophthalmol. 2016;27(2):164–9.

    Article  Google Scholar 

  2. Neelakantan A, Parrish R. Risk factors for wound healing. Chapter 90. In: Shaarawy T, Sherwood M, Hitchings R, Crowston J, editors. Glaucoma. 2nd ed. Edinburgh: Elsevier Limited; 2015. p. 891.

    Google Scholar 

  3. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003;48(3):314–46.

    Article  Google Scholar 

  4. Bergen T, Van de Velde S, Vandewalle E, Moons L. Improving patient outcomes following glaucoma surgery: state of the art and future perspectives. Clin Ophthalmol. 2014;8:857–67.

    Article  Google Scholar 

  5. Georgoulas S, Dahlmann-Noor A, Brocchini S, Khaw PT. Modulation of wound healing during and after glaucoma surgery. Prog Brain Res. 2008;173:237–54.

    Article  CAS  Google Scholar 

  6. Välimäki J, Uusitalo H. Immunohistochemical analysis of extracellular matrix bleb capsules of functioning and non-functioning glaucoma drainage implants. Acta Ophthalmol. 2014;92(6):524–8.

    Article  Google Scholar 

  7. Jung KI, Lee SB, Kim JH, Park CK. Foreign body reaction in glaucoma drainage implant surgery. Invest Ophthalmol Vis Sci. 2013;54(6):3957–64.

    Article  Google Scholar 

  8. Nakamura-Shibasaki M, Ko JA, Takenaka J, Chikama T, Sonoda KH, Kiuchi Y. Matrix metalloproteinase and cytokine expression in Tenon fibroblasts during scar formation after glaucoma filtration or implant surgery in rats. Cell Biochem Funct. 2013;31(6):482–8.

    Article  CAS  Google Scholar 

  9. Luttikhuizen DT, Harmsen MC, Van Luyn MJ. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng. 2006;12(7):1955–70.

    Article  CAS  Google Scholar 

  10. Jung KI, Lim SA, Park HY, Park CK. Visualization of blebs using anterior-segment optical coherence tomography after glaucoma drainage implant surgery. Ophthalmology. 2013;120(5):978–83.

    Article  Google Scholar 

  11. Thieme H, Choritz L, Hofmann-Rummelt C, Schloetzer-Schrehardt U, Kottler UB. Histopathologic findings in early encapsulated blebs of young patients treated with the Ahmed glaucoma valve. J Glaucoma. 2011;20(4):246–51.

    Article  Google Scholar 

  12. Ishida K, Netland PA, Costa VP, Shiroma L, Khan B, Ahmed II. Comparison of polypropylene and silicone Ahmed glaucoma valves. Ophthalmology. 2006;113(8):1320–6.

    Article  Google Scholar 

  13. Bhartiya S, Shaarawy T. Chapter 113: Surgical technique 3 (Ahmed glaucoma valve drainage implant). In: Boyle IV JW, Ryan McManus J, Netland PA, editors. Glaucoma. 2nd ed. Edinburgh: Elsevier Limited; 2015. p. 1078.

    Google Scholar 

  14. Fraser S. Trabeculectomy and antimetabolites. Br J Ophthalmol. 2004;88(7):855–6.

    Article  CAS  Google Scholar 

  15. European Glaucoma Society Editrice Dogma. Terminology and guidelines for glaucoma. 2nd ed. Savona, Italy: European Glaucoma Society Editrice Dogma; 2003.

    Google Scholar 

  16. Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk. Drugs Aging. 1999;15(6):439–50.

    Article  CAS  Google Scholar 

  17. Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88(4):752–9.

    Article  CAS  Google Scholar 

  18. Yazdani S, Doozandeh A, Pakravan M, Ownagh V, Yaseri M. Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial. Eur J Ophthalmol. 2016;27(4):411–6.

    Article  Google Scholar 

  19. Sisto D, Vetrugno M, Trabucco T, Cantatore F, Ruggeri G, Sborgia C. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta Ophthalmol Scand. 2007;85(3):267–71.

    Article  CAS  Google Scholar 

  20. Greenfield DS, Liebmann JM, Jee J, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol. 1998;116(4):443–7.

    Article  CAS  Google Scholar 

  21. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology. 1996;103(4):650–6.

    Article  CAS  Google Scholar 

  22. Skuta GL, Beeson CC, Higginbotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1992;99(3):438–44.

    Article  CAS  Google Scholar 

  23. Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G. Five- minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol. 1992;110(8):1150–4.

    Article  CAS  Google Scholar 

  24. Shapiro MS, Thoft RA, Friend J, Parrish RK, Gressel MG. 5-Fluorouracil toxicity to the ocular surface epithelium. Invest Ophthalmol Vis Sci. 1985;26(4):580–3.

    CAS  PubMed  Google Scholar 

  25. Seong GJ, Park C, Kim CY, et al. Mitomycin-C induces the apoptosis of human Tenon’s capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 protease. Invest Ophthalmol Vis Sci. 2005;46(10):3545–52.

    Article  Google Scholar 

  26. Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology. 2004;11(6):1071–6.

    Article  Google Scholar 

  27. Kurnaz E, Kubaloglu A, Yilmaz Y, Koytak A, Ozerturk Y. The effect of adjunctive mitomycin C in Ahmed glaucoma valve implantation. Eur J Ophthalmol. 2005;15(1):27–31.

    Article  Google Scholar 

  28. Zhou M, Wang W, Huang W, Zhang X. Use of mitomycin C to reduce the incidence of encapsulated cysts following Ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. BMC Ophthalmol. 2014;14:107.

    Article  Google Scholar 

  29. Alvarado JA, Hollander DA, Juster RP, Lee LC. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmol. 2008;146(2):276–84.

    Article  CAS  Google Scholar 

  30. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res. 1994;59(6):723–7.

    Article  CAS  Google Scholar 

  31. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci. 1999;40(10):2225–34.

    CAS  PubMed  Google Scholar 

  32. Li Z, Van Bergen T, Van de Veire S, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009;50(11):5217–25.

    Article  Google Scholar 

  33. Van Bergen T, Vandewalle E, Van de Veire S, et al. The role of different VEGF isoforms in scar formation after glaucoma filtration surgery. Exp Eye Res. 2011;93(5):689–99.

    Article  Google Scholar 

  34. Iliev ME, Domig D, Wolf-Schnurrbursch U, et al. Intravitreal Bevacizumab (Avastin®) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142:1054–6.

    Article  CAS  Google Scholar 

  35. Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, Dewerchin M, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009;50:5217–25.

    Article  Google Scholar 

  36. Mahdy RA. Adjunctive use of bevacizumab versus mitomycin C with Ahmed valve implantation in treatment of pediatric glaucoma. J Glaucoma. 2011;20:458–63.

    Article  Google Scholar 

  37. Miraftabi A, Nilforushan N. Wound dehiscence and device migration after subconjunctival bevacizumab injection with Ahmed glaucoma valve implantation. J Ophthalmic Vis Res. 2016;11(1):112–5.

    Article  Google Scholar 

  38. Xiong Q, Li Z, Zhu Y, et al. Anti-VEGF agents with or without antimetabolites in trabeculectomy for glaucoma: a meta-analysis. PLoS One. 2014;9(2):e88403.

    Article  Google Scholar 

  39. Van Bergen T, Moons L, Vandewalle E, et al. Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery. Acta Ophthalmol. 2015;93(7):667–78.

    Article  Google Scholar 

  40. Desai RU, Singh K, Lin SC. Intravitreal ranibizumab as an adjunct for Ahmed valve surgery in open-angle glaucoma: a pilot study. Clin Exp Ophthalmol. 2013;41:155–8.

    Article  Google Scholar 

  41. Rojo-Arnao M, Albis-Donado O, Literas-Cardin M, Kahook MY, Gil-Carrazco F. Adjunctive Bevacizumab in patients undergoing Ahmed Valve implantation: a pilot study. Ophthalmic Surg Lasers Imaging. 2011;42(2):132–7.

    PubMed  Google Scholar 

  42. Popescu V, et al. Clinical use of Bevacizumab in treating refractory glaucoma. J Med Life. 2015;8:8–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. McIlraith I, Buys Y, Campbell RJ, Trope GE. Ocular massage for intraocular pressure control after Ahmed valve insertion. Can J Ophthalmol. 2008;43(1):48–52.

    Article  Google Scholar 

  44. Smith M, Geffen N, Alasbali T, Buys YM, Trope GE. Digital ocular massage for hypertensive phase after Ahmed valve surgery. J Glaucoma. 2010;19(1):11–4.

    Article  Google Scholar 

  45. Bhartiya S, Shaarawy T. Chapter 78: Tenon’s cyst formation, wound healing, and bleb evaluation. In: Shaarawy T, Sherwood M, Hitchings R, Crowston J, editors. Glaucoma. 2nd ed. Edinburgh: Elsevier Limited; 2015. p. 781.

    Google Scholar 

  46. Quaranta L, Floriani I, Hollander L, Poli D, Katsanos A, Konstas AG. Needle revision with 5-fluorouracil for the treatment of Ahmed glaucoma valve filtering blebs: 5-fluoruracil needling revision can be a useful and safe tool in the management of failing Ahmed glaucoma valve filtering blebs. J Glaucoma. 2016;25(4):e367–71.

    Article  Google Scholar 

  47. Eibschitz-Tsimhoni M, Schertzer RM, Musch DC, Moroi SE. Incidence and management of encapsulated cysts following Ahmed glaucoma valve insertion. J Glaucoma. 2005;14(4):276–9.

    Article  Google Scholar 

  48. Amoozgar B, Wei X, Hui Lee J, Bloomer M, Zhao Z, Coh P, He F, Luan L, Xie C, Han Y. A novel flexible microfluidic meshwork to reduce fibrosis in glaucoma surgery. PLoS One. 2016;12(3):e0172556.

    Article  Google Scholar 

  49. Jung KI, Park CK. Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantation. Drug Design Devel Ther. 2016;10:1477–88.

    CAS  Google Scholar 

  50. Na JH, Sung KR, Shin JA, Moon JI. Antifibrotic effects of pirfenidone on Tenon’s fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil. Graefes Arch Clin Exp Ophthalmol. 2015;253:1537–47.

    Article  CAS  Google Scholar 

  51. Schoenberg ED, Blake DA, Swann FB, Parlin AW. Effect of two novel sustained-release drug delivery systems on bleb fibrosis: an in vivo glaucoma drainage device study in a rabbit model. Transl Vis Sci Technol. 2015;4:4–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Manitoba, Winnipeg, MB, Canada

    Nadia Ríos-Acosta

  2. Instituto Mexicano de Oftalmologia, Queretaro, Mexico

    Sonia Corredor-Casas

Authors
  1. Nadia Ríos-Acosta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sonia Corredor-Casas
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dr. Shroff’s Charity Eye Hospital, New Delhi, India

    Monica Gandhi

  2. Fortis Memorial Research Institute, Gurgaon, India

    Shibal Bhartiya

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ríos-Acosta, N., Corredor-Casas, S. (2019). Histological Considerations of Glaucoma Drainage Devices. In: Gandhi, M., Bhartiya, S. (eds) Glaucoma Drainage Devices. Springer, Singapore. https://doi.org/10.1007/978-981-13-5773-2_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-5773-2_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-5772-5

  • Online ISBN: 978-981-13-5773-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation